Drug Trial Radar · NCT07478991
Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
376
Planned (sponsor's estimate)
Start
Jul 2, 2026
Primary completion
Apr 2030
Study completion Apr 2030
Sponsor
- Lead sponsor
- PETHEMA FoundationAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 18, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if Venetoclax+Azacytidine+Quizartinib works better than standard therapy (Venetoclax+Azacytdine) to treat naïve adult patients with acute myeloid leukemia (AML) who are not suitable for standard induction therapy due to age, co-morbidities or other risk factors. The main question it aims to answer is: \- Does the combination of Venetoclax+Azacytidine+Quizartinib show more probability of overall survival than Venetoclax+Azacytdine? Researchers will compare Venetoclax+Azacytidine+Quizartinib to Venetoclax+Azacytdine to see if Venetoclax+Azacytidine+Quizartinib works better than Venetoclax+Azacytdine to treat AML. Participants will be randomized to one of the two treatment arms in a 1:1 ratio, both of which will have treatment cycles of 28 days.
Conditions
- Acute Myeloid Leukemia, Adult
Interventions
AzacitidineDrug
Subcutaneous injection during the first 7 days of each 28-day cycle until disease progression or end of study
VenetoclaxDrug
Oral Venetoclax during the first 7 days of each 28-day cycle until disease progression or end of study
QuizartinibDrug
Oral Quizartinib during days 8 to 21 of each 28-day cycle until disease progression or end of study .
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall SurvivalTime frame: 4 years
Locations
52 sites in 1 country. Site status is shown where the registry gives one.
Complejo Hospitalario de Albacete
Albacete, Spain · Not yet recruiting
Hospital General Universitario Dr. Balmis
Alicante, Spain · Not yet recruiting
Hospital Universitario Torrecárdenas
Almería, Spain · Recruiting
Institut Catalá d´Oncología (ICO Badalona)
Badalona, Spain · Recruiting
Hospital Galdakao-Usansolo
Barakaldo, Spain · Recruiting
Hospital Universitario de Basurto
Barakaldo, Spain · Recruiting
Hospital Universitario de Burgos
Burgos, Spain · Not yet recruiting
Complejo Hospitalario de Cáceres
Cáceres, Spain · Not yet recruiting
Hospital Universitario Puerta del Mar
Cadiz, Spain · Recruiting
H. General de Castellón
Castelló, Spain · Not yet recruiting
Complejo Hospitalario Regional Reina Sofía
Córdoba, Spain · Not yet recruiting
Hospital Universitario Donostia
Donostia / San Sebastian, Spain · Recruiting
Hospital Universitario Juan Ramón Jiménez
Huelva, Spain · Not yet recruiting
Complejo Hospitalario de Gran Canaria Dr. Negrin
Las Palmas de Gran Canaria, Spain · Recruiting
Complejo Hospitalario Universitario Insular-Materno Infantil
Las Palmas de Gran Canaria, Spain · Recruiting
Hospital Universitario de Canarias
Las Palmas de Gran Canaria, Spain · Recruiting
Hospital Universitario Lucus Augusti
Lugo, Spain · Not yet recruiting
Fundación Jiménez Díaz
Madrid, Spain · Not yet recruiting
HLA Hospital Universitario Moncloa
Madrid, Spain · Not yet recruiting
Hospital Clínico San Carlos
Madrid, Spain · Not yet recruiting
Hospital Infanta Leonor
Madrid, Spain · Not yet recruiting
Hospital Univeristario Ramón y Cajal
Madrid, Spain · Not yet recruiting
Hospital Universitario HM Sanchinarro
Madrid, Spain · Recruiting
HU Quirónsalud Madrid
Madrid, Spain · Not yet recruiting
H.U. Puerta de Hierro Majadahonda
Majadahonda, Spain · Not yet recruiting
Hospital Universitario Virgen de la Victoria
Málaga, Spain · Recruiting
Althaia, Xarxa Asistencial de Manresa
Manresa, Spain · Recruiting
Hospital Clinico Universitario Virgen de La Arrixaca
Murcia, Spain · Recruiting
Clínica Universitaria de Navarra
Pamplona, Spain · Not yet recruiting
Hospital Virgen Del Puerto
Plasencia, Spain · Not yet recruiting
Hospital Clínico Universitario de Salamanca.
Salamanca, Spain · Not yet recruiting
Complejo Hospitalario Universitario Nuestra Señora de la Candelaria
Santa Cruz de Tenerife, Spain · Recruiting
H. Marqués de Valdecilla
Santander, Spain · Not yet recruiting
Complejo Hospitalario Universitario de Santiago (CHUS)
Santiago de Compostela, Spain · Recruiting
Hospital General de Segovia
Segovia, Spain · Not yet recruiting
Hospital Universitario Virgen de Valme
Seville, Spain · Not yet recruiting
Hospital Universitario Virgen Del Rocío
Seville, Spain · Not yet recruiting
Hospital General Universitario de Toledo
Toledo, Spain · Recruiting
H. Dr. Peset
Valencia, Spain · Recruiting
Hospital Arnau de Vilanova-Valencia
Valencia, Spain · Recruiting
Showing 40 of 52 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.